Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Israel

BMI Revises Pharmaceutical Market Size

May 2011 | Industry Trend Analysis

BMI View: Israel claims to have a very efficient healthcare system that means it does not need to spend as much of its GDP on healthcare. In truth, the government's fiscal austerity and sick funds keep the most expensive innovative drugs unavailable, while cheaper generics help to control overall cost. Furthermore, private Israeli hospitals are run more efficiently than many other state-funded

To read the full article, please choose one of the following options:

Subcribers please log in

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries